Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide with Melphalan-Prednisone in Elderly Multiple Myeloma
NCT00644306Phase 3Terminated
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by CHRU de Nancy - Hôpital Central. Started Apr 2002; status: terminated.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00644306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644306.